Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Receptor Agonist
100%
A1 Receptor
100%
Glaucoma
100%
Glucagon-like
100%
Short-term Mortality
100%
Acutely Admitted Patients
100%
Blood Test
100%
Long-term Mortality
100%
Machine Learning Models
100%
External Validation
100%
Positive Predictive Value
66%
Blood Samples
66%
Emergency Department
66%
Mortality Prediction
66%
Confidence Interval
50%
Hazard Ratio
40%
Emergency Patients
33%
Light Gradient Boosting Machine
33%
Danish Universities
33%
Sensitivity Specificity
33%
University Hospital
33%
Primary Data Sources
33%
Area under the Receiver Operating Characteristic Curve
33%
Mortality Risk
33%
Prognostic Model
33%
Matthews Correlation Coefficient
33%
Prediction Model
33%
AUC Value
33%
Negative Predictive Value
33%
Emergency Admissions
33%
Clinical Biochemistry
33%
Present Challenges
33%
Antihyperglycemic
20%
Birth Timing
20%
Low Risk
20%
Nested Case-control Study
10%
Surgical Intervention
10%
Treatment Initiation
10%
National Cohort Study
10%
Second-line Treatment
10%
Free Control
10%
Adjusted Hazard Ratio
10%
Metformin
10%
Treatment Other
10%
Time Use
10%
Conditional Logistic Regression
10%
Prolonged Treatment
10%
Drug Formulation
10%
Agonist Treatment
10%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Glucagon-Like Peptide-1 Agonist
100%
Glaucoma
100%
Hazard Ratio
50%
Drug Therapy
20%
Eye Injury
10%
Glycon
10%
Eye Surgery
10%
Logistic Regression Analysis
10%
Childbirth
10%
Case-Control Study
10%
Surgery
10%
